SiliconBeat

Micrel, the San Jose chip maker that won a nasty proxy battle last year with its then-largest independent shareholder, Obrem Capital, decided it better extend its poison-pill defense against hostile takeovers by one more year. The shareholder rights plan  set up a year ago was to have expired today, but will now live on until March 24, 2010, according to a regulatory filing.

On March 19, Micrel entered into a Read the rest of this entry »

The board of directors at CV Therapeutics decided to extend by a year the shareholders rights plan they have in place to fend off hostile takeovers. The plan, otherwise known as a poison pill, was set to expire Read the rest of this entry »

A month after borrowing $25 million at a minimum of 12.5 percent, the parent company of the Jamba Juice franchise, said today that its board of directors has adopted a “Stock Purchase Rights Plan” that it says is “designed to enable all Jamba Inc. stockholders to realize the full value of their investment” and to provide them “fair and equal treatment” in the event that “an unsolicited attempt is made to acquire the company “without paying all stockholders full and fair value,” according to a press release the company issued this morning.

The market is pegging that value at Read the rest of this entry »

AP Pharma decided to increase the amount of shares its biggest shareholder may accumulate before the company would need to swallow its poison pill, er, shareholder rights plan in order to deter him from gaining control, according to a regulatory filing Tuesday.

On Oct. 1, AP Pharma (ticker: APPA) amended its Preferred Shares Rights Agreement dated Dec. 18, 2006, to allow  Kevin Tang and his affiliated companies to acquire up to Read the rest of this entry »

Back in November the board of LookSmart, the San Francisco supplier of online advertising software, enacted an anti-takeover device known in governance parlance as a shareholder rights plan, more commonly called a “poison pill,” designed to be swallowed in the event of a hostile takeover bid.

Under the plan, current shareholders were given options to buy Read the rest of this entry »

In their fight to gain control of CNET Networks’ board, a group of investors led by JANA Partners has set up their own Web site dedicated to the effort.

Read the rest of this entry »

Micrel started playing defense Tuesday against a growing challenge from Obrem Capital Management, an investment firm that has amassed almost 10.7 million shares of the San Jose chip maker, which represents 14.9 percent of its shares outstanding.

The company set up a”limited duration shareholder rights plan,” more colorfully known as a poison pill intended to be swallowed should some entity — say Obrem Capital — were to acquire 15 percent of Micrel’s shares outstanding.

Read the rest of this entry »